-
1دورية أكاديمية
المؤلفون: Janssen, J. C., van Dijk, B., de Joode, K., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Jalving, M., de Jonge, M. J. A., Joosse, A., Kapiteijn, E., Kamphuis-Huismans, A. M., Naipal, K. A. T., Piersma, D., Rikhof, B., Westgeest, H. M., Vreugdenhil, G., Oomen-de Hoop, E.
المصدر: BMC Cancer; 5/23/2024, Vol. 24 Issue 1, p1-7, 7p
مصطلحات موضوعية: NIVOLUMAB, IMMUNE checkpoint inhibitors, TERMINATION of treatment, PROGNOSIS, MELANOMA, RESEARCH protocols
مصطلحات جغرافية: NETHERLANDS
-
2دورية أكاديمية
المؤلفون: Virtakoivu, R. (Reetta), Rannikko, J. H. (Jenna H.), Viitala, M. (Miro), Vaura, F. (Felix), Takeda, A. (Akira), Lönnberg, T. (Tapio), Koivunen, J. (Jussi), Jaakkola, P. (Panu), Pasanen, A. (Annika), Shetty, S. (Shishir), de Jonge, M. J. (Maja J. A.), Robbrecht, D. (Debbie), Ma, Y. T. (Yuk Ting), Skyttä, T. (Tanja), Minchom, A. (Anna), Jalkanen, S. (Sirpa), Karvonen, M. K. (Matti K.), Mandelin, J. (Jami), Bono, P. (Petri), Hollmén, M. (Maija)
وصف الملف: application/pdf
-
3دورية أكاديمية
المؤلفون: van der Velden, D. L., Hoes, L. R., van der Wijngaart, H., Henegouwen, J. M. van Berge, van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R., Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M., Smit, E. F., de Langen, A. J., Mehra, N., Labots, M., Kapiteijn, E., Sleijfer, S., Cuppen, E., Verheul, H. M. W., Gelderblom, H., Voest, E. E.
المصدر: van der Velden , D L , Hoes , L R , van der Wijngaart , H , Henegouwen , J M V B , van Werkhoven , E , Roepman , P , Schilsky , R L , de Leng , W W J , Huitema , A D R , Nuijen , B , Nederlof , P M , van Herpen , C M L , de Groot , D J A , Devriese , L A , Hoeben , A , de Jonge , M J A , Chalabi , M , Smit , E F ....
مصطلحات موضوعية: CLINICAL-TRIALS, OPEN-LABEL, PHASE-II, RESPONSE ASSESSMENT, TARGETED THERAPY, 2-STAGE DESIGNS, MULTICENTER, CRITERIA, CANCERS, TUMORS
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1038/s41586-019-1600-xTest
https://hdl.handle.net/11370/03d8c4b4-6d8a-4a56-b7bb-9d1a07aefc94Test
https://research.rug.nl/en/publications/03d8c4b4-6d8a-4a56-b7bb-9d1a07aefc94Test
https://pure.rug.nl/ws/files/99785862/s41586_019_1600_x.pdfTest -
4مؤتمر
المؤلفون: Bono, P., Pasanen, A., Verlingue, L., de Jonge, M. J. A., de Miguel, M. J., Skytta, T., Iivanainen, S., Shetty, S., Ma, Y. T., Graham, Donna, Arora, S. P., Jaakkola, P., Yap, C., Jalkanen, S., Hollmen, M., Koivunen, J., Minchom, A. R.
المساهمون: Terveystalo Hospital and University of Helsinki, Helsinki, Finland
العلاقة: https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.2645Test; Bono P, Pasanen A, Verlingue L, de Jonge MJA, de Miguel MJ, Skytta T, et al. Promising clinical benefit rates in advanced cancers alongside potential biomarker correlation in a phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680300868.; http://hdl.handle.net/10541/625797Test; Journal of Clinical Oncology
الإتاحة: https://doi.org/10.1200/JCO.2022.40.16_suppl.2645Test
http://hdl.handle.net/10541/625797Test -
5دورية أكاديمية
المؤلفون: Schöffski, P., Besse, B., Gauler, T., de Jonge, M. J. A., Scambia, G., Santoro, A., Davite, C., Jannuzzo, M. G., Petroccione, A., Delord, J.-P.
مصطلحات موضوعية: Original article
وصف الملف: text/html
العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/mdu566v2Test; http://dx.doi.org/10.1093/annonc/mdu566Test
الإتاحة: https://doi.org/10.1093/annonc/mdu566Test
http://annonc.oxfordjournals.org/cgi/content/short/mdu566v2Test -
6دورية أكاديمية
المؤلفون: Gadea, O. Saavedra Santa, Greil, R., De Jonge, M. J. A., Tan, D., Jerusalem, G., Damian, S., Grell, P., Wainberg, Z., Wolf, J., Joerger, M., Carlino, M. S., Kasper, S., Yap, T. A., Otero, J., Yang, X., Nesbitt, V., Kim, J., Lee, L. Ho, Choudhury, S., Leal, T. A.
مصطلحات موضوعية: ddc:no
العلاقة: Gadea, O. Saavedra Santa, Greil, R., De Jonge, M. J. A., Tan, D., Jerusalem, G., Damian, S., Grell, P., Wainberg, Z., Wolf, J., Joerger, M., Carlino, M. S., Kasper, S., Yap, T. A., Otero, J., Yang, X., Nesbitt, V., Kim, J., Lee, L. Ho, Choudhury, S. and Leal, T. A. (2021). Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC). Ann. Oncol., 32. S. S552 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
الإتاحة: https://kups.ub.uni-koelnTest.de/60434/
-
7دورية أكاديمية
المؤلفون: van Beek, C. G. E. M., Cirkel, D. G., de Jonge, M. J., Hartog, N.
المصدر: Aquatic Geochemistry ; volume 27, issue 1, page 49-61 ; ISSN 1380-6165 1573-1421
مصطلحات موضوعية: Geochemistry and Petrology, Geophysics
-
8دورية أكاديمية
المؤلفون: Lankheet, N A G, Kloth, J S L, Gadellaa-van Hooijdonk, C G M, Cirkel, G A, Mathijssen, R H J, Lolkema, M P J K, Schellens, J H M, Voest, E E, Sleijfer, S, de Jonge, M J A, Haanen, J B A G, Beijnen, J H, Huitema, A D R, Steeghs, N
المساهمون: Sub Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Monitoring, Fatigue, Feasibility Studies, Female, Gastrointestinal Diseases, Hematologic Diseases, Humans, Indoles, Male, Middle Aged, Neoplasms, Nervous System Diseases, Pilot Projects, Protein Kinase Inhibitors, Pyrroles, Salvage Therapy
وصف الملف: image/pdf
-
9دورية أكاديمية
المؤلفون: Schöffski, P., Besse, B., Gauler, T., de Jonge, M. J. A., Scambia, G., Santoro, A., Davite, C., Jannuzzo, M. G., Petroccione, A., Delord, J.-P.
مصطلحات موضوعية: Original article
وصف الملف: text/html
العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/mdu566v1Test; http://dx.doi.org/10.1093/annonc/mdu566Test
الإتاحة: https://doi.org/10.1093/annonc/mdu566Test
http://annonc.oxfordjournals.org/cgi/content/short/mdu566v1Test -
10دورية أكاديمية
المؤلفون: Lin, C. C., Joerger, M., Grell, P., Chiappori, A. A., Leal, T. A., Kasper, S., Jerusalem, G., Goncalves, A., Wolf, J., De Braud, F., de Jonge, M. J. A., Otero, J., Chhagan, S., Cipolletta, D., Morris, E., Chowdhury, N. R., Hurtado, F. K., Tan, D. S.
مصطلحات موضوعية: ddc:no
العلاقة: Lin, C. C., Joerger, M., Grell, P., Chiappori, A. A., Leal, T. A., Kasper, S., Jerusalem, G., Goncalves, A., Wolf, J., De Braud, F., de Jonge, M. J. A., Otero, J., Chhagan, S., Cipolletta, D., Morris, E., Chowdhury, N. R., Hurtado, F. K. and Tan, D. S. (2020). Continuous vs intermittent adenosine 2A receptor (A2AR) inhibition in preclinical colon cancer (CC) models and in a Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients ( pts) with non-small cell lung cancer (NSCLC). Eur. J. Cancer, 138. S. S12 - 2. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
الإتاحة: https://kups.ub.uni-koelnTest.de/31656/
النص الكامل